REQUEST A DEMO
Total
USD $0.00
Search more companies

Tus-Pharmaceutical Group Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tus-Pharmaceutical Group Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is the largest Chinese medicine, Western medicine and biochemical joint pharmaceutical companies in Hunan. The Company focused on research, development of traditional Chinese medicine recipes, Western medicine and biological products, has refined the ancient Han Dynasty (oral solution, tablets), Urethane health, heart and brain protect Thai oral, the ancient Han Bao spring bolt, Qingshu detoxification granules, the Western Han Dynasty of ancient wine varieties such as the eight formulations of 63 proprietary Chinese medicines, health products and lomefloxacin Hydrochloride injection, clindamycin phosphate injection, infusion formulations of 147 with seven varieties of western medicine preparations and human injection of blood protein, human immunoglobulin injection more than 40 varieties of bio-pharmaceutical.

Headquarters
No. 1 Luojinqiao, Yanfeng District, Hengyang City, Hunan Province (Yanfeng District Industrial Project Cluster) Headquarters Office Building
Hengyang; Hunan; Postal Code: 421001

Contact Details: Purchase the Tus-Pharmaceutical Group Co., Ltd. report to view the information.

Website: http://www.tuspharma.cn

Basic Information
Total Employees:
Purchase the Tus-Pharmaceutical Group Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Tus-Pharmaceutical Group Co., Ltd. report to view the information.
Registered Capital:
Purchase the Tus-Pharmaceutical Group Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Tus-Pharmaceutical Group Co., Ltd. report to view the information.
Incorporation Date:
March 25, 1993
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
24.47%
Purchase this report to view the information.
19.11%
Purchase this report to view the information.
1.9%
Purchase this report to view the information.
0.83%
Purchase this report to view the information.
0.67%
Subsidiaries
Guangdong Xiantong Pharmaceutical Co., Ltd.
100%
Guhan Chinese Medicine Co., Ltd.
100%
Hengyang Ancient Han Culture Communication Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Tus-Pharmaceutical Group Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-21.26%
Total operating revenue
-21.41%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-0.89%
Total equity
-1.21%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.45%
Quick Ratio
-0.12%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?